Literature DB >> 19040936

Gastroschisis, atresia, dysmotility: surgical treatment strategies for a distinct clinical entity.

J Duncan Phillips1, Mehul V Raval, Courtney Redden, Timothy M Weiner.   

Abstract

PURPOSE: Intestinal atresia (IA) occurs in 10% to 20% of infants born with gastroschisis (GS). We describe a distinct subset of these children with severe dysmotility, without mechanical intestinal obstruction, and with adequate intestinal length for enteral nutrition and propose possible treatment strategies.
METHODS: A total of 177 patients with GS managed at a single institution between 1993 and 2007 were retrospectively reviewed.
RESULTS: Twenty-one (12%) patients had IA. Six (29%) did well, with gradual progression to full diet; 1 died at birth because of complete midgut infarction; 1 died of necrotizing enterocolitis; 4 with short bowel syndrome (SBS) (small bowel length, 30-41 cm) died of liver failure because of total parenteral nutrition (3) or sepsis (1). Nine (43%) were felt to have gastroschisis/atresia/dysmotility, defined as adequate small bowel length for survival as measured at time of laparotomy (mean, 146 cm; range, 66-233 cm), massive intestinal dilatation, and stasis. Of 9 patients with gastroschisis/atresia/dysmotility, 5 (56%) survived. All had surgery to "rescue" their dysfunction intestine, at mean age 128 days (range, 52-271 days): 4 had tapering enteroplasties of mean 37 cm (range, 5-115 cm)-all 4 survived; 3 had diverting stomas created for intestinal decompression, followed by stoma closure-1 survived; 1 nonsurvivor had a Kimura "patch"; 1 nonsurvivor underwent redo anastomosis. Survivors weaned off total parenteral nutrition at mean age 331 days after rescue surgery (range, 42-814 days).
CONCLUSIONS: More than one third of patients with GS/IA appear to have significant intestinal dysmotility without true SBS nor obstruction. Successful treatment of these infants may be achieved with the use of tapering enteroplasty and/or temporary diverting stomas.

Entities:  

Mesh:

Year:  2008        PMID: 19040936     DOI: 10.1016/j.jpedsurg.2008.08.065

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

1.  Intestinal atresia in association with gastroschisis: a 26-year review.

Authors:  Rania Kronfli; Timothy J Bradnock; Atul Sabharwal
Journal:  Pediatr Surg Int       Date:  2010-07-30       Impact factor: 1.827

2.  The role of intermediate filaments in maintaining integrity and function of intestinal epithelial cells after massive bowel resection in a rat.

Authors:  I Sukhotnik; Y Ben Shahar; Y Pollak; T Dorfman; H Kreizman Shefer; Z E Assi; N Mor-Vaknin; A G Coran
Journal:  Pediatr Surg Int       Date:  2017-10-17       Impact factor: 1.827

3.  Isolated prenatal ultrasound findings predict the postnatal course in gastroschisis.

Authors:  Barbora Frybova; Radovan Vlk; Alena Kokesova; Michal Rygl
Journal:  Pediatr Surg Int       Date:  2015-02-20       Impact factor: 1.827

4.  Cisapride improves enteral tolerance in pediatric short-bowel syndrome with dysmotility.

Authors:  Bram P Raphael; Samuel Nurko; Hongyu Jiang; Kristen Hart; Daniel S Kamin; Tom Jaksic; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-05       Impact factor: 2.839

5.  Bowel-defect disproportion in gastroschisis: does the need to extend the fascial defect predict outcome?

Authors:  Arash Safavi; Erik Skarsgard; Sonia Butterworth
Journal:  Pediatr Surg Int       Date:  2012-02-14       Impact factor: 1.827

6.  Gut inflammation and expression of ICC in a fetal lamb model of fetoscopic intervention for gastroschisis.

Authors:  Thomas Krebs; Michael Boettcher; Hansjörg Schäfer; Georg Eschenburg; Katharina Wenke; Birgit Appl; Beate Roth; Thomas Andreas; Carla Schmitz; Rebecca Fahje; Birthe Jacobsen; Bastian Tiemann; Konrad Reinshagen; Kurt Hecher; Robert Bergholz
Journal:  Surg Endosc       Date:  2014-03-20       Impact factor: 4.584

7.  Intestinal dysmotility after bowel resection in rats is associated with decreased ghrelin and vimentin expression and loss of intestinal cells of Cajal.

Authors:  Igor Sukhotnik; Yoav Ben-Shahar; Yulia Pollak; Shlomi Cohen; Hadar Moran-Lev; Tal Koppelmann; Migel Gorenberg
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-12-16       Impact factor: 4.052

8.  Evolution of critically ill patients with gastroschisis from three tertiary centers.

Authors:  Ana Cristina A Tannuri; Lourenço Sbragia; Uenis Tannuri; Luanna M Silva; Antonio José G Leal; Augusto Frederico S Schmidt; Antonio G Oliveira-Filho; Joaquim Murray Bustorff-Silva; Yvone A M V A Vicente; Maria de Fátima G S Tazima; Flávio O Pileggi; Alexandra L Camperoni
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Does administering albumin to postoperative gastroschisis patients improve outcome?

Authors:  Ana Cristina A Tannuri; Luanna M Silva; Antonio José G Leal; Augusto César F de Moraes; Uenis Tannuri
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Ultrasound markers for prediction of complex gastroschisis and adverse outcome: longitudinal prospective nationwide cohort study.

Authors:  C C M M Lap; L R Pistorius; E J H Mulder; M Aliasi; W L M Kramer; C M Bilardo; T E Cohen-Overbeek; E Pajkrt; D Tibboel; R M H Wijnen; G H A Visser; G T R Manten
Journal:  Ultrasound Obstet Gynecol       Date:  2020-06       Impact factor: 7.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.